Docket Room.
SB 211·KY·senate

AN ACT relating to coverage for prescription drugs.

FailedFiled Feb 19, 2026
Latest Action

to Committee on Committees (S)

Feb 19, 2026

Email me when SB 211 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 211. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill forces Kentucky health insurance plans to place biosimilar drugs on their formularies when the biosimilar’s wholesale acquisition cost is lower than the brand reference product and to offer the same or better cost‑sharing, while banning extra prior‑auth or step‑therapy requirements. It also amends statutes governing limited health‑service benefit plans, post‑secondary institution liability insurance, and the state employee health‑insurance program, adding provisions such as special enrollment for pregnant women and a ban on using state funds for abortion coverage. The act would have applied to plans issued on or after Jan. 1, 2027 but did not pass.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 211

3 free questions a day, no account

History

  1. to Committee on Committees (S)
  2. introduced in Senate

Sponsors

  • C. Richardson

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 211 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 211 free

Or ask your AI assistant about SB 211 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice